Oral anticoagulants are the cornerstone of stroke risk prevention in patients with atrial fibrillation, regardless of whether sinus rhythm is restored. Evidence from two new randomized trials questions the need for long-term treatment with oral anticoagulants after successful ablation of atrial fibrillation and promises to change clinical practice.
Oral anticoagulant therapy after ablation for atrial fibrillation / G.F. Romiti, M. Proietti. - In: NATURE REVIEWS. CARDIOLOGY. - ISSN 1759-5002. - (2026 Jan). [Epub ahead of print] [10.1038/s41569-026-01248-0]
Oral anticoagulant therapy after ablation for atrial fibrillation
M. ProiettiUltimo
2026
Abstract
Oral anticoagulants are the cornerstone of stroke risk prevention in patients with atrial fibrillation, regardless of whether sinus rhythm is restored. Evidence from two new randomized trials questions the need for long-term treatment with oral anticoagulants after successful ablation of atrial fibrillation and promises to change clinical practice.| File | Dimensione | Formato | |
|---|---|---|---|
|
s41569-026-01248-0.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Licenza:
Nessuna licenza
Dimensione
780.4 kB
Formato
Adobe PDF
|
780.4 kB | Adobe PDF | [it] Default value: Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I metadati presenti in AIR sono rilasciati con licenza CCO mentre i file delle pubblicazioni sono rilasciati con licenza CC BY-SA, salvo diversa indicazione. In caso di violazione di copyright, contattare l'assistenza di AIR




